Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-18 Purchase |
2022-05-19 4:30 pm |
Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Chairman & CEO |
37,500 | $0.6433 | $24,124 | 303,616 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-20 Option Award |
2024-06-21 4:20 pm |
N/A 2034-06-19 |
Omega Therapeutics Inc. | OMGA | SCHADE CHRISTIAN S Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-05-09 Option Award |
2024-05-13 4:38 pm |
N/A N/A |
INTEGRA LIFESCIENCES HOLDINGS CORP | IART | SCHADE CHRISTIAN S Director |
8,696 | $0 | 63,503 (Direct) |
View |
| 2023-07-10 Option Award(A) |
2024-02-09 5:00 pm |
N/A 2033-07-09 |
Omega Therapeutics Inc. | OMGA | SCHADE CHRISTIAN S Director |
36,713 | $0 | 36,713 (Direct) |
View |
| 2024-02-07 Option Award |
2024-02-09 4:57 pm |
N/A 2034-02-06 |
Omega Therapeutics Inc. | OMGA | SCHADE CHRISTIAN S Director |
512,848 | $0 | 512,848 (Direct) |
View |
| 2023-07-10 Option Award |
2023-07-12 4:21 pm |
N/A 2023-07-09 |
Omega Therapeutics Inc. | OMGA | SCHADE CHRISTIAN S Director |
36,713 | $0 | 36,713 (Direct) |
View |
| 2023-05-12 Option Award |
2023-05-16 4:18 pm |
N/A N/A |
INTEGRA LIFESCIENCES HOLDINGS CORP | IART | SCHADE CHRISTIAN S Director |
4,486 | $0 | 54,807 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 5:06 pm |
N/A 2032-07-28 |
Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Director |
80,000 | $0 | 317,846 (Direct) |
View |
| 2022-06-03 Tax Withholding |
2022-06-07 5:05 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Chairman & CEO |
65,770 | $0.805 | 237,846 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-17 4:44 pm |
N/A N/A |
INTEGRA LIFESCIENCES HOLDINGS CORP | IART | SCHADE CHRISTIAN S Director |
4,721 | $0 | 50,321 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 5:03 pm |
N/A 2032-03-10 |
Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Chairman & CEO |
527,800 | $0 | 693,816 (Direct) |
View |
| 2022-02-25 Tax Withholding |
2022-03-01 5:02 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Chairman & CEO |
21,644 | $1.74 | 166,016 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-17 4:23 pm |
N/A N/A |
INTEGRA LIFESCIENCES HOLDINGS CORP | IART | SCHADE CHRISTIAN S Director |
3,426 | $0 | 45,600 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 7:05 pm |
N/A 2031-02-25 |
Aprea Therapeutics Inc. | APRE | SCHADE CHRISTIAN S Chairman & CEO |
494,500 | $0 | 516,660 (Direct) |
View |
| 2020-05-13 Option Award |
2020-05-15 4:07 pm |
N/A N/A |
INTEGRA LIFESCIENCES HOLDINGS CORP | IART | SCHADE CHRISTIAN S Director |
5,009 | $0 | 42,174 (Direct) |
View |